NCNA
NuCana plc
There isn't enough reported data to score NCNA yet.
NCNA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
NCNA's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
NCNA PE Valuation
NCNA has no meaningful PE right now: it lost money over the past year.
NCNA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect NCNA's losses to grow, with revenue holding steady.
NCNA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$1,857.47 | +$2,355.11 |
| Q4 2024 | -$2,797.37 | +$1,552.63 |
| Q3 2024 | -$3,964.14 | +$3,991.80 |
| Q2 2024 | -$4,388.55 | +$3,175.99 |
| Q1 2024 | -$4,212.58 | +$3,120.87 |
| Q4 2023 | -$4,350.00 | +$3,205.97 |
| Q3 2023 | -$7,955.94 | -$2,845.38 |
| Q2 2023 | -$7,564.54 | -$1,719.91 |
NCNA lost $3.95 per share over the past year, a smaller loss than the year before.
NCNA Quarterly Revenue
NCNA's revenue is shrinking: $0 last quarter.
NCNA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.6M | +$3.5M |
| Q1 2026 | -$4.3M | -$147.7K |
| Q4 2025 | -$1.6M | +$8.4M |
| Q3 2025 | $1.6M | +$7.8M |
| Q2 2025 | -$6M | -$4.3M |
| Q1 2025 | -$4.2M | +$3.7M |
| Q4 2024 | -$10M | -$9.8M |
| Q3 2024 | -$6.2M | +$7.4M |
NCNA has burned cash in almost every quarter: −$7M over the past year, against −$26M the year before.
NCNA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +23.8K shares |
| 1 year | +13687% | +4.2M shares |
| 3 years | +39858% | +4.2M shares |
| 5 years | +40423% | +4.2M shares |
| Available history | +64553% | +4.2M shares |
NCNA has 4M diluted shares, up 13687% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NCNA hasn't bought back shares in the past year.
NCNA Net Leverage
NCNA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NCNA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.6 | Neutral |
| Stochastic | 5.2 | Oversold |
NCNA's weekly RSI is 32 (neutral) and its Stochastic is 5 (oversold).
NCNA PE vs Healthcare Sector
NCNA has no meaningful PE right now: it lost money over the past year.
NCNA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.04 | 11% below |
| 20 week MA | $1.27 | 27% below |
| 50 week MA | $1.96 | 53% below |
| 100 week MA | $42.1 | 98% below |
| 200 week MA | $1,248.8 | 100% below |
NCNA is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
NCNA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31,000.0 | $25,000.0 | -19% |
| 2021 | $25,000.0 | $12,350.0 | -51% |
| 2022 | $12,350.0 | $3,900.0 | -68% |
| 2023 | $3,900.0 | $1,480.0 | -62% |
| 2024 | $1,480.0 | $284.0 | -81% |
| 2025 | $284.0 | $3.31 | -99% |
| 2026 YTD | $3.31 | $0.93 | -72% |
NCNA has finished every year since 2020 lower, and it's down 72% so far in 2026.